(S)-(-)-N-乙酰基-1-甲基苄胺 | 19144-86-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: (S)-(-)-N-乙酰基-1-甲基苄胺
• 英文名称: (S)-N-acetyl-1-phenylethylamine
• 英文别名: (S)-N-(1-phenylethyl)acetamide；N-((S)-1-phenylethyl)acetamide；N-(1-phenylethyl)acetamide；N-[(1S)-1-phenylethyl]acetamide
• CAS: 19144-86-6
• 化学式: C₁₀H₁₃NO
• 分子量: 163.219
• InChiKey: PAVMRYVMZLANOQ-QMMMGPOBSA-N

物化性质

• 熔点：
  102-103 °C
• 沸点：
  290.31°C (rough estimate)
• 密度：
  1.0508 (rough estimate)
• 稳定性/保质期：
  遵照规定使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2924299090
• 储存条件：
  存放在阴凉干燥处即可。

SDS

Name:	(S)-(-)-N-Acetyl-1-Methylbenzylamine Material Safety Data Sheet
Synonym:	None Known
CAS:	19144-86-6

Section 1 - Chemical Product MSDS Name:(S)-(-)-N-Acetyl-1-Methylbenzylamine Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
19144-86-6	(S)-(-)-N-Acetyl-1-Methylbenzylamine	ca. 100	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 19144-86-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystalline powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 102 - 103 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density:
Molecular Formula: C10H13NO
Molecular Weight: 163.22

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 19144-86-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(S)-(-)-N-Acetyl-1-Methylbenzylamine - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 19144-86-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 19144-86-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 19144-86-6 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (S)-(-)-N-乙酰基-1-甲基苄胺 在 Schwartz's reagent 、 水 作用下， 以 四氢呋喃 为溶剂， 反应 0.03h， 以93%的产率得到(S)-(-)- α-甲基苄胺
  参考文献：
  名称：

  Chemoselective N-deacetylation under mild conditions

  摘要：

  描述了一种温和高效的化学选择性去乙酰化方法，该方法使用施瓦茨试剂在室温下迅速进行。温和和中性的条件使得在一些常见保护基团（即Boc、Fmoc、Cbz、Ts）存在的情况下能够进行正交去乙酰化。去保护条件不会引起手性氨基中心的任何表异构化。

  DOI：

  10.1039/c3ob41971a
• 作为产物：
  描述：

  苯乙酮肟 在 bis(norbornadiene)rhodium(l)tetrafluoroborate 、 chloro(1,5-cyclooctadiene)rhodium(I) dimer 、 (R)-BIDIME 、 四丁基氟化铵 、 iron(II) acetate 、 溶剂黄146 作用下， 以 四氢呋喃 、 六氟苯 、 甲苯 为溶剂， 反应 15.0h， 生成 (S)-(-)-N-乙酰基-1-甲基苄胺
  参考文献：
  名称：

  α-芳基酰胺对映选择性硼氢化反应合成手性α-氨基叔硼酸酯

  摘要：

  以 BI-DIME 作为手性配体和 (Bpin)2 作为试剂的 α-芳基酰胺的铑催化不对称硼氢化反应首次以良好的收率和优异的对映选择性（高达 99 % ee）。

  DOI：

  10.1021/jacs.5b03760

文献信息

• Spiro[4,4]-1,6-Nonadiene-Based Diphosphine Oxides in Lewis Base Catalyzed Asymmetric Double-Aldol Reactions
  作者：Panke Zhang、Zhaobin Han、Zheng Wang、Kuiling Ding

  DOI：10.1002/anie.201305846

  日期：2013.10.11

  Symmetry swap: A C2‐chiral spiro diphosphine oxide (SpinPO) has been found to be highly efficient and enantioselective in the catalysis of double‐aldol reactions of ketones and aldehydes to give the corresponding optically active double‐aldol products, which can be readily transformed into optically active C3‐ and pseudo‐C3‐symmetric molecules.

  对称交换：发现C 2-手性螺二氧化膦（SpinPO）在催化酮和醛的双羟醛反应以得到相应的旋光双羟醛产物方面是高效且对映选择性的转化为旋光的C 3-和假C 3-对称分子。
• Modular Monodentate Phosphoramidite Ligands for Rhodium-Catalyzed Enantioselective Hydrogenation
  作者：Yan Liu、Kuiling Ding

  DOI：10.1021/ja052749l

  日期：2005.8.1

  A new class of monodentate phosphoramidite ligands (DpenPhos) has been developed on the basis of the modular concept for Rh(I)-catalyzed asymmetric hydrogenations of a variety of olefin derivatives, affording the corresponding optically active compounds in excellent yields and enantioselectivities. The ligands have the advantages of facile preparation, tunable structure, and broad scope of substrates

  基于 Rh(I) 催化的各种烯烃衍生物的不对称氢化的模块化概念，开发了一类新的单齿亚磷酰胺配体 (DpenPhos)，以优异的产率和对映选择性提供相应的光学活性化合物。这些配体在其 Rh(I) 络合物催化的不对称氢化中具有制备容易、结构可调和底物范围广等优点。
• A Single Lipase-Catalysed One-Pot Protocol Combining Aminolysis Resolution and Aza-Michael Addition: An Easy and Efficient Way to Synthesise β-Amino Acid Esters
  作者：Fan Xu、Qiongsi Wu、Xiaoyang Chen、Xianfu Lin、Qi Wu

  DOI：10.1002/ejoc.201500760

  日期：2015.8

  was developed to obtain chiral β-amino acid esters with lipase B from Candida antarctica (CAL-B) as the only catalyst. This method is conducted under mild reaction conditions and is very easy to handle. After a series of detailed optimization studies, ten racemic aromatic or aliphatic amines were subjected to this one-pot procedure, and twelve chiral β-amino acid esters and ten chiral amides were successfully

  开发了一种结合 aza-Michael 加成和氨解拆分的新型一锅法，以来自南极念珠菌 (CAL-B) 的脂肪酶 B 作为唯一催化剂获得手性 β-氨基酸酯。该方法在温和的反应条件下进行，非常容易操作。经过一系列详细的优化研究，10 种外消旋芳香族或脂肪族胺经过此一锅法处理，成功合成了 12 种手性 β-氨基酸酯和 10 种手性酰胺，其 ee 值在理论产率下具有优异的值。放大程序也没有明显降低反应速率或对映选择性，这使得该方法适用于手性 β-氨基酸酯的大规模生产。
• HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS
  申请人：CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD.

  公开号：US20170253614A1

  公开（公告）日：2017-09-07

  A series of hepatitis C virus (HCV) inhibitors and compositions and applications thereof in the preparation of drugs for treating chronic HCV infection. Especially, a series of compounds that are used as NS5A inhibitors, and compositions and uses thereof in the preparations of drugs.

  一系列丙型肝炎病毒（HCV）抑制剂及其组合物，以及在制备用于治疗慢性HCV感染的药物时的应用。特别是一系列用作NS5A抑制剂的化合物，以及在药物制剂中的组合物和用途。
• Synthesis of Chiral Hydroxyl Phospholanes from <scp>d</scp>-mannitol and Their Use in Asymmetric Catalytic Reactions
  作者：Wenge Li、Zhaoguo Zhang、Dengming Xiao、Xumu Zhang

  DOI：10.1021/jo000066c

  日期：2000.6.1

  Strategies for protection and deprotection of OH-groups in the presence of phosphines have been explored. Rate acceleration in the Baylis-Hillman reaction was observed when a hydroxyl phosphine was used as the catalyst. Rhodium complexes with chiral bisphospholanes are highly enantioselective catalysts for the asymmetric hydrogenation of various kinds of functionalized olefins such as dehydroamino

  手性羟基一膦3 [（2S，3S，4S，5S）-3,4-二羟基-2，5-二甲基-1-苯基膦烷]和双膦酸酯5a [1,2-双[（2S，3S，4S，5S） -3,4-二羟基-2,5-二甲基磷杂环戊烷基]苯]和5b [1,2-双[（2S，3S，4S，5S）-2,5-二乙基-3,4-二羟基磷杂环戊基]苯]从现成的D-甘露醇中以高收率获得。已经研究了在膦存在下保护和脱保护OH-基团的策略。当使用羟基膦作为催化剂时，在Baylis-Hillman反应中观察到速率加速。铑与手性双膦酸酯的络合物是高度对映选择性的催化剂，用于各种官能化烯烃（如脱氢氨基酸衍生物，衣康酸衍生物和烯酰胺）的不对称氢化。